Author

Dalton Dacus

Kansas State UniversityORCID 0000-0001-9588-5048Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Ana Orive-RamosiD· 1 shared Beau BaarsiD· 1 shared Bijaya GaireiD· 1 shared Evangelia MatenoglouiD· 1 shared Evripidis GavathiotisiD· 1 shared Frank P. McCormickiD· 1 shared Grant BrookeiD· 1 shared Joseph P. Lyssikatos· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana Orive-RamosORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 6, 2026

Binding kinetics enable tumor-selective MAPK and growth suppression by a Type 1 RAF Inhibitor

Mathieu Desaunay, Tara Peters, Evangelia Matenoglou…·Poulikos I. Poulikakos

This study identifies ELV-3111, a Type 1 RAF inhibitor that selectively suppresses MAPK and tumor growth by exploiting distinct binding kinetics, showing efficacy in RAS-mutant and BRAF-mutant models.

DOI 10.64898/2026.10.05.756774

humanexperimental assay

𝕏 PostBluesky

Cancer BiologymSpherePeer-reviewedFeb 26, 2026

Cutaneous human papillomavirus E6 impairs the cGAS-STING pathway

Grant Brooke, Dalton Dacus, Rose Pollina…·Nicholas A. Wallace

This study shows that {beta}-HPV 8 E6 impairs the cGAS-STING pathway, reducing innate immune responses to micronuclei and promoting cell proliferation.

7 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky